Taliglucerase Alfa Patent Expiration
Taliglucerase Alfa is Used for treating Gaucher disease. It was first introduced by Pfizer Inc
Taliglucerase Alfa Patents
Given below is the list of patents protecting Taliglucerase Alfa, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Elelyso | US8790641 | Production of high mannose proteins in plant culture and therapeutic uses thereof | Oct 18, 2025 | Pfizer |
| Elelyso | US8227230 | Human lysosomal proteins from plant cell culture |
Feb 24, 2024
(Expired) | Pfizer |
| Elelyso | US8741620 | Human lysosomal proteins from plant cell culture |
Feb 24, 2024
(Expired) | Pfizer |
Taliglucerase Alfa's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List